Introduction {#Sec1}
============

A number of studies have shown that 1,1-dichloro-2,2-bis(4-chlorophenyl) ethane (4,4′-DDE), the major metabolite of 1,1′-bis(4-chlorophenyl)-2,2,2-trichloroethane (4,4′-DDT), is present at high levels in different environmental media in China (Grung et al. [@CR6]; Yin et al. [@CR32]; Zhang et al. [@CR35]; Zhou et al. [@CR36]) even though technical DDT was prohibited for agricultural use in 1983 (Yu et al. [@CR33]). Qiu et al. ([@CR19]) stated that the use of dicofol in China has become an important source of DDT after the prohibition. This can be explained by the manufacturing process of 4,4′-dicofol being synthesized from DDT. China was the largest consumer of dicofol globally, from 2000 to 2012, with a cumulative usage of 19,500 MT, occupying 69% of the global total amount (Li et al. [@CR14]).

Dicofol (trade name, Kelthane) has been widely used as an organochlorine acaricide that is applied to protect citrus and cotton cultivations from mites (Thiel et al. [@CR24]; Vonier et al. [@CR27]). Dicofol is produced from technical DDT through a pathway including chlorination to form the intermediate 1,1-bis(4-chlorophenyl)-1,2,2,2-tetrachloroethane (α-Cl-DDT), and followed by hydrolysis thereof to form dicofol (Qiu et al. [@CR19]). It is estimated that 93% of 4,4′-DDT is converted to 4,4′-dicofol while only 37% of 2,4′-DDT is converted to 2,4′-dicofol probably due to steric hindrance for the formation of 2,4′- α-Cl-DDT (Qiu et al. [@CR18]). The lower reactivity of 2,4-DDT results in an increased ratio of 4,4′-dicofol/2,4′-dicofol to around 10 (Qiu et al. [@CR18]). Hence, dicofol analyzed in the present study refers to 4,4′-dicofol.

Due to its structural similarity to DDT, dicofol is considered to be of similar concern as DDT and its metabolites DDE and dichlorodiphenyldichloroethane (DDD). These concerns relate to persistence, bioaccumulation, environmental long-range transport, and adverse effect in wildlife and humans (UNEP [@CR25]). In 2011, the Japanese government rejected the import of Chinese-produced eel due to high levels of dicofol residues, reflecting a severe contamination of this acaricide in China (Wang et al. [@CR29]).

Dicofol has been listed as a persistent toxic compound in a series of multilateral agreements, e.g., Convention on Long-range Transboundary Air Pollution Protocol on persistent organic pollutants (POPs), and banned in many developed countries (Li et al. [@CR14]). Dicofol has been proposed (2013) as a candidate for POPs in the Stockholm Convention (UNEP [@CR25]). However, the inclusion of dicofol among the legacy POPs is controversial. For example, there is a lack of evidence of dicofol's environmental stability. Dicofol is not stable under alkaline condition when it decomposes to dichlorobenzophenone (DCBP) (UNEP [@CR25]). Dicofol has been demonstrated to easily undergo transformation to DCBP when classical gas chromatography (GC) injection techniques, such as high-temperature split/splitless injectors, are used (Fujii et al. [@CR5]).

The environmental research on dicofol and exposure to dicofol is limited. It is mainly restricted by analytical difficulties. Fujii et al. ([@CR5]) used GC coupled to mass spectrometry (MS) in splitless mode to compare dicofol and its related pesticides in breast milk from China, Korea, and Japan assuming dicofol decomposed to DCBP completely. However, according to our experience, dicofol cannot be expected to be quantitatively transformed to DCBP. In addition, it is known that other acaricides, e.g., chlorobenzilate and chloropropylate, may form DCBP (Knowles and Ahmad [@CR13]). Even DDT itself is metabolically transformed to DCBP (Heberer and Dünnbier [@CR8]). Accordingly, dicofol is not the only source of DCBP.

Wiemeyer et al. ([@CR31]) used GC with an electron capture detector (ECD) for analysis of dicofol residues in eggs and carcasses of captive American kestrels (*Falco sparverius*). The authors injected dicofol in a temperature-programmed mode at several concentration levels of the analyte and measured the corresponding DCBP amount being formed. They then corrected for dicofol residues in the samples. However, the decomposition ratios are suspected to vary among single injections. Consequently, the use of classical GC injection techniques is problematic for the analysis of dicofol.

Other pretreatment and instrumental techniques, e.g., reversed-phase high-performance liquid chromatography (Han et al. [@CR7]), spectrophotometry (Pandey et al. [@CR17]), and molecularly imprinted solid-phase extraction (Wang et al. [@CR29]), have been applied according to the scientific literature.

In the present study, a simple solution for improved analysis of dicofol and DCBP is proposed by using an on-column injection technique. The sample was injected directly onto the GC column at a temperature below the boiling point of the solvent. The advantage with this technique is that little or no thermal degradation occurs compared to what happens when splitless injections are done. The applicability of the method is evaluated by the recovery of dicofol and DCBP in spiked cod samples.

Material and methods {#Sec2}
====================

Solvents and chemicals {#Sec3}
----------------------

The solvents were all of the highest quality available on the market. All glassware were heated at 300 °C overnight before being used. Aluminum oxide (90 active basic, 0.063--0.200 mm) was supplied from Merck and heated to 130 °C overnight prior to use. Cod (*Gadus morhua*) muscle from the North Atlantic was bought from ICA Supermarket, Sweden, for the recovery study.

The chemical structure of analytes involved in the present study is shown in Fig. [1](#Fig1){ref-type="fig"}. Dicofol (99%) and DCBP (98.9%) were purchased from Dr. Ehrenstorfer GmbH, Germany. 2,3,3′,4,4′,5,5′-Heptachlorobiphenyl (CB-189), 2,2′,3,3′,4,5,6,6′-octachlorobiphenyl (CB-200), and 2,2′,3,3′,4,5′,6,6′-octachlorobiphenyl (CB-201) were purchased from AccuStandard (New Haven, USA). 4′-Me-5′-MeSO~2~-CB106 (MSF-IS) was synthesized in-house.Fig. 1Chemical structure of contaminants involved in the study

Recovery study {#Sec4}
--------------

The recovery study included both dicofol and DCBP. Dicofol was spiked to cod samples at two levels (1 and 10 ng). DCBP, with two levels (9.2 and 46 ng), was spiked to another batch of cod samples. The lower level of each compound is approximately around ten times the limit of quantification whereas the higher level is still in the linear range of ECD. For each compound and concentration level, five replicates were analyzed. In addition to those 20 samples spiked with standards, three cod samples were left unspiked, as control samples. CB-200 and MSF-IS, which have been commonly used in our research group as internal standard (Hovander et al. [@CR9]; Zhou et al. [@CR37]), were added to the samples as surrogate standards for dicofol and DCBP, respectively. CB-201 was added as volumetric standard prior to analysis for recovery calculation.

Extraction and clean-up {#Sec5}
-----------------------

A scheme for the analytical procedure applied is presented in Fig. [2](#Fig2){ref-type="fig"}. Cod samples were homogenized with a steel blender as a pool. Extraction was performed according to the Jensen refined extraction method of lean fish with a minor modification that iso-hexane replaced with *n*-hexane (Jensen et al. [@CR11]). One portion (approximately 8 g) of homogenized cod muscle was weighed and then transferred to a centrifuge tube containing isopropanol (IPR, 25 mL) and iso-hexane/diethyl ether (DEE) (3:1, *v*/*v*, 20 mL). Target analyte and surrogate standard were spiked to the sample (Table [1](#Tab1){ref-type="table"}). After homogenization and centrifugation, the extracts were poured into a separatory funnel (150 mL). Re-extraction was performed using IPR (10 mL) and iso-hexane/DEE (40 mL) and the extracts were combined in a separatory funnel. The extracts were then washed with a mixture of sodium chloride (0.9%) in hydrochloric acid (0.2 M hydrochloric acid, 50 mL), inverted 30 times and let stand for phase separation. After 1 h, the water phase was removed to an E-flask. The funnel was washed with the sodium chloride solution (20 mL) again and the separation procedure was then repeated. Finally, the organic phase was collected into a preweighted beaker. The beaker was left in the fume hood at room temperature overnight for evaporation until a stable lipid weight was reached. The lipid was dissolved with iso-hexane (4 mL) and transferred to a 15-mL test tube. Lipid was removed by conc. sulfuric acid (2 mL). The iso-hexane phase was taken out whereas the acid phase was re-extracted with iso-hexane (3 mL) and the combined organic phase was evaporated to 0.2 mL for dicofol analysis.Fig. 2Scheme for analysis of the analytes used in the recovery study Table 1Recovery (%) of 4,4′-dicofol (*Difocol*), 4,4′- dichlorobenzophenone (*DCBP*), and their corresponding surrogate standards, 2,2′,3,3′,4,5,6,6′-octachlorobiphenyl (CB-200) and 4′-Me-5′-MeSO~2~-CB106 (MSF-IS), respectively, in cod samplesDose spikedDicofolCB-200DicofolCB-200DCBPMSF-ISDCBPMSF-IS1 ng2 ng10 ng2 ng9.2 ng2.5 ng46 ng2.5 ngCod 177897897133142151117Cod 268766793628214096Cod 356628210090138152119Cod 462746989100100154131Cod 56584819910812313292Mean6577759699117146111SD810742625917The test solution was spiked with 1 ng dicofol and 9.2 ng DCBP for the low dose and 10 ng and 46 ng for the high dose, respectively

Extraction of DCBP {#Sec6}
------------------

DCBP acts as a Lewis base and partitions into the conc. sulfuric acid in the lipid removal treatment step and needs to be re-extracted from the acid. The acid phase fraction was placed in an ice-bath and diluted with cold distilled water (2 mL) which was subsequently extracted with iso-hexane (3 mL) twice. The combined iso-hexane phase was concentrated to 0.5 mL by a gentle nitrogen flow. The samples were further cleaned up on a basic aluminum oxide column (0.9 g), packed in a Pasteur pipette. The column was preconditioned with *n*-hexane/DEE (9:1, *v*/*v*, 5 mL). The sample was applied to the column and analytes eluted with *n*-hexane/DEE (9:1, *v*/*v*, 12 mL), and thereafter with DEE (10 mL). The solvent volume was reduced by a gentle flow of nitrogen. Prior to instrumental analysis, CB-201 was added as the volumetric standard. The final volume was adjusted to 0.1 mL for GC-ECD analysis.

Instrumental analysis {#Sec7}
---------------------

A Varian 450-GC equipped with a Varian CP-8400 autosampler and a Varian 1079 programmed temperature vaporizing (PTV) inlet was used. To be able to do an on-column injection, a 2-m non-polar methyl deactivated capillary precolumn (J&W Scientific) with an inner diameter of 0.53 mm, big enough to allow a 26-gauge needle tip to enter the bore, is press-fit connected to an injector liner that is tapered in the middle. The liner is positioned in such a way that the needle tip releases the sample inside the precolumn bore. Automated injections of 1 μL were made in splitless mode, and the inlet temperature of the injector was programmed as follows: initial temperature of 55 °C for 2 min, a 200 °C/min ramp to a final temperature of 280 °C which was maintained throughout the analysis; compressed air was used to cool the injector to the starting temperature. The analytical column (TR-5MS, 30 m × 0.25 mm × 0.1 μm, Thermo Scientific) was connected to the precolumn with a zero dead volume adapter. Helium was used as carrier gas at a constant flow of 1.2 mL/min. The temperature program for the oven started at 55 °C for 2 min, a 15 °C/min ramp up to 300 °C, and maintained there for 8 min. An ECD was used for detection and operated at 325 °C with nitrogen as make-up gas (25 mL/min).

Quality control {#Sec8}
---------------

One procedural solvent blank was used in each batch of five samples. Three unspiked cod samples (control samples) were analyzed in parallel with the spiked samples. Neither dicofol nor DCBP was detected in any procedural blank or control sample. The replicate samples were mixed and analyzed in different batches to avoid any systematic bias or contamination.

Results and discussion {#Sec9}
======================

In order to validate the method, a recovery study was conducted in cod. The recovery of dicofol and DCBP is presented in Table [1](#Tab1){ref-type="table"}. The mean recovery of dicofol was 65 ± 8% (56--77%) at low dose (1 ng) and 75 ± 7% (67--82%) at high dose (10 ng), which are regarded as a satisfying result. Figure [3](#Fig3){ref-type="fig"} shows the chromatogram of dicofol by using on-column injection. No DCBP was observed during the instrumental analysis in any spiked sample or control sample. The recovery of CB-200 was 77 ± 10% (62--89%) for low dose and 96 ± 4% (89--100%) for high dose. The good recovery of CB-200 at the two levels indicates that dicofol can be analyzed together with other PCB congeners.Fig. 3GC-ECD chromatogram of 4,4′-dicofol (*Dicofol*) and 2,2′,3,3′,4,5,6,6′-octachlorobiphenyl (*CB200*) recovery study on cod by on-column injection. **a** *Dicofol* reference. **b** *Dicofol* low dose (1 ng). **c** *Dicofol* high dose (10 ng). *CB201* spiked as volumetric standard

The recovery of DCBP was 99 ± 26% (62--133%) and 146 ± 9% (132--152%) at low and high doses, respectively (Table [1](#Tab1){ref-type="table"}). The recovery of MSF-IS was 117 ± 25% (82--142%) and 111 ± 17% (92--131%) at low and high doses, respectively. The reason for such difference in the recovery of DCBP may be due to an unstable baseline in the chromatography (Figure [4](#Fig4){ref-type="fig"}). The volumetric standard CB-201 elutes in the early part of the slope and MSF-IS elutes at the top of the slope. DCBP elutes in the early part of chromatography; hence, the peak abundance would not be interfered by the slope, but quantification would be influenced when CB-201 was used as an internal standard. The results indicate that MSF-IS is not an optimal surrogate standard for DCBP analysis.Fig. 4GC-ECD chromatogram of 4,4′-dichlorobenzophenone (*DCBP*) and 4′-Me-5′-MeSO~2~-CB106 (*MSF-IS*) recovery study of cod performed by on-column injection. **a** *DCBP* reference. **b** *DCBP* high dose (46 ng). **c** *DCBP* low dose (9.2 ng). *CB201* spiked as volumetric standard

Prior to the recovery test, a number of pretests were performed. Figures [3](#Fig3){ref-type="fig"}a and [5](#Fig5){ref-type="fig"}c promote a comparison of the two GC chromatograms resulting from dicofol injected in the standard splitless mode (Fig. [5](#Fig5){ref-type="fig"}c) and in the on-column mode (Fig. [3](#Fig3){ref-type="fig"}a). It is apparent that dicofol is transformed to DCBP when the injections are done in the splitless mode (Fig. [5](#Fig5){ref-type="fig"}c). Furthermore, some extra unknown peaks appear in the chromatograms which have yet to be identified. The instrumental parameter and condition affect the occurrence of those peaks, resulting in low reproducibility. Therefore, it is not recommended to use classical split-splitless injector for dicofol analysis. However, if dicofol was injected on an on-column injector, no DCBP was observed in the chromatograms (Fig. [3](#Fig3){ref-type="fig"}a). Hence, the solution to the apparent problem is to eliminate sample contact with glass inserts. Testing revealed that dicofol degraded to DCBP on all instances when the sample was introduced to the analytical column via a glass liner, no matter the injection technique used. Those tested were the following: (1) hot splitless injection where the sample is vaporized inside a glass liner at elevated temperatures; (2) temperature-programmed injection where the sample is released inside a glass liner at a start temperature below or at the boiling point of the solvent and then heated rapidly; or (3) direct injection by the use of a tapered glass liner where the sample is deposited inside the walls of the glass insert and forced onto the analytical column by raising the temperature rapidly. Different techniques require also different types of glass liners, and different brands and trademarks were tested, all leading to the same final result. Our conclusion is accordingly to inject the sample directly inside the bore of the analytical column which was achieved by utilizing a precolumn with an inner diameter big enough to accept the size of a syringe.Fig. 5GC-ECD chromatogram of 4,4′-dichlorobenzophenone (*DCBP*) and 4,4′-dicofol (*Dicofol*) injected on a standard split/splitless injector. **a** *DCBP* reference. **b** *Dicofol* transformation to *DCBP* by potassium hydroxide treatment. **c** *Dicofol* reference. *CB189* used as retention time standard

Since the half-life of dicofol in the environment is shorter compared to legacy POPs, e.g., DDT (UNEP [@CR26]), it is doubtful that dicofol can be detected in the environmental compartment in its own form. It has been reported that dicofol can undergo photolysis to form DCBP (Chen et al. [@CR3]) and also transform under alkaline conditions (Walsh and Hites [@CR28]). In addition, it has been found that dicofol could be metabolically transformed to DCBP in rats and mice (Brown et al. [@CR2]; Brown and Casida [@CR1]). These findings might explain why dicofol has been rarely detected in environmental studies (c.f. Table [2](#Tab2){ref-type="table"}).Table 2Summary of dicofol residue in environmental samples reported in the scientific literatureMatrixExtractionClean-upInstrumentTarget ionsDetection limitRecoveryResidue levelLocationReferenceAppleLiquid extractionColumn chromatographyGC-ECD5 ng/g93--96n.d.India(Singh et al. [@CR22])Mother's milkLiquid extractionGPC, silica gel columnGC-MS139, 2500.2 ng/g915.8--64 (9.6) ng/g l.w.China(Fujii et al. [@CR5])Mother's milkLiquid extractionGPC, silica gel columnGC-MS139, 2500.2 ng/g910.8--3.0 (1.9) ng/g l.w.Korea(Fujii et al. [@CR5])Mother's milkLiquid extractionGPC, silica gel columnGC-MS139, 2500.2 ng/g91\<0.1--2.7 (0.32) ng/g l.w.Japan(Fujii et al., [@CR5])TeaMicrowave-assisted steam distillationSPEGC-ECD0.2 ng/g81--11053--990 ng/gChina(Ji et al. [@CR12])TomatoLiquid extractionFlorisil columnGC-ECD0.007 μg/g870.002--0.4 μg/gMorocco(Salghi et al. [@CR21])Human adipose tissueLiquid extractionGPCGC-MS-MS250, 1392.91 ng/g fatChina(Wang et al. [@CR30])SoilLiquid extractionGC-ECD1.85 ng/g8411 ng/gPakistan(Syed and Malik [@CR23])SoilUltrasonic-extractionFlorisil columnGC-MS250, 1391.35 ng/g11 ng/gChina(Lv et al. [@CR15])EggLiquid extractionAcid silicaGC-ECD6 ng/g70--9829--36 ng/gPakistan(Malik et al. [@CR16])EggLiquid extractionAcid silicaGC-ECD6 ng/g70--98n.d.---21.6 ng/gPakistan(Malik et al. [@CR16])

Conc. sulfuric acid is commonly used for lipid removal for POP analysis. However, this step will partition Lewis bases to the conc. sulfuric acid phase, a property first applied in environmental analysis to isolate aryl methyl sulfone compounds, as methylsulfonyl-PCBs (MeSO~2~-PCBs) from other neutral organohalogen compounds (Jensen and Jansson [@CR10]). Also, dibenzophenone compounds are Lewis bases that are partitioning to the conc. sulfuric acid phase in a partitioning with e.g. hexane. Since the sulfuric acid has been commonly discarded, this can explain why DCBP is rarely detected and reported from actual environmental samples.

Alternatives on pretreatment may be considered to further improve the method proposed herein. Cod was used for the recovery study as it has low contaminant levels and low lipid content, the latter to minimize matrix effects. Species with high lipid content require use of larger quantities of conc. sulfuric acid to remove the lipids, which may influence the recoveries. Therefore, other lipid removal methods, e.g., gel permeation chromatography or acetonitrile partitioning, might be used to remove the lipids prior to conc. sulfuric acid treatment. According to the literatures (c.f. Tables [2](#Tab2){ref-type="table"} and [3](#Tab3){ref-type="table"}), the most common techniques for dicofol analysis are GC-ECD and GC-MS (Fujii et al. [@CR5]; Malik et al. [@CR16]; Wang et al. [@CR30]; Wiemeyer et al. [@CR31]). There is a possibility to explore conversion of dicofol to DCBP by treatment with sodium hydroxide after conc. sulfuric acid treatment. By this alternative method, dicofol and DCBP are separated by sulfuric acid and then dicofol can be transformed to DCBP by sodium hydroxide treatment before classical GC analysis by split/splitless injector (Fig. [5](#Fig5){ref-type="fig"}b). A significant disadvantage with sodium hydroxide treatment compared with on-column injection is that it is limiting the method to become only dicofol-specific. Therefore, the method presented herein is preferable.Table 3Summary of method for dicofol analysis reported elsewhereMatrixExtractionClean-upInstrumentParent ionsDetection limitRecoverySpecial techniqueSpiked amountReferenceCodLiquid extractionSulfuric acid basic aluminum columnGC-ECD0.01 ng/g l.w.56--81On-column injection1 and 10 ngPresent studyMinced samplesLiquid extractionMISPEGC-ECD0.1 ng/g86--101Molecularly imprinted solid-phase extraction1--10 ng/g(Wang et al. [@CR29])Water, milk, tomato, beans, grapesUV-visible spectrophotometer94--99Spectrophotometric15--25 μg(Pandey et al. [@CR17])FishLiquid extractionNH~2~-SPEGC-MS139 (250, 141)1 ng/g79--870.02--0.1 ng/g(Chen et al. [@CR4])OrangeSilica gelGC-ECD70 ng/g87--950.5--10 μg/g(Ribeiro et al. [@CR20])TeaLiquid extractionDispersive solid phase extraction (d-SPE)GC-MS UHPLC-MS-MS250, 252, 251, 2540.09 μg/g107UHPLC-MS-MS(Zhang et al. [@CR34])

Conclusion {#Sec10}
==========

In the present study, a method composed of liquid extraction, sulfuric acid clean-up and separation, on-column injection, was developed for dicofol and its major decomposition product DCBP. Dicofol does not break down when on-column injection is used. It should be pointed out that the application of the method may not be limited to analysis of dicofol. On-column injection can be used for compounds that are thermo-labile.

The sulfuric acid treatment can separate chemicals containing a ketone group from neutral compounds in addition to removing lipids. However, improvements and/or alternatives are suggested, e.g., use gel permeation chromatography to remove lipids before sulfuric acid, further clean-up for DCBP phase. The method is a step forward in dicofol environmental assessment and particularly promising to be applied to those environmental samples from dicofol hot spot areas.
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